Bullish Notes: Analysts Initiate Coverage on Dorman Products, QXO, Netgear, and Immunome

Netgear analyst initiates coverage on the company with a Buy rating and a $35 price target. Wells Fargo analyst initiates coverage on Dorman Products with an Overweight rating and a $175 price target. Benchmark analyst initiates coverage on QXO with a Buy rating and a $50 price target. Evercore ISI Group analyst initiates coverage on Immunome with an Outperform rating and an $18 price target.

In a series of significant moves, several leading financial services firms have initiated coverage on four companies, each with unique ratings and price targets. These analysts' opinions provide valuable insights for investors seeking to understand the market's expectations for these firms.

Netgear (NTGR)
Stifel has initiated coverage on Netgear (NTGR) with a "Buy" rating and a price target of $35.00 USD [1]. The firm expects the stock to outperform its peers, driven by robust networking technologies for businesses, homes, and service providers. Netgear operates in two segments: NETGEAR for Business and Connected Home. Analysts forecast double-digit revenue gains in the business segment, with initiatives such as a professional audio-visual platform, expanded broadcasting partnerships, and the acquisition of cybersecurity firm Exium. The company aims to return to operating profitability by 2027. In the home networking segment, a refreshed product lineup and stabilizing consumer demand are expected to boost performance. Subscription services like Armor and Insight are also identified as long-term drivers. The $35 target is based on a 1.0 times sales multiple and discounted cash flow analysis, reflecting confidence in the turnaround while accounting for risks in execution. Netgear currently trades at just 0.6 times estimated 2026 sales, a steep discount to peers.

Dorman Products (DORM)
Wells Fargo has initiated coverage on Dorman Products (DORM) with an "Overweight" rating and a price target of $175.00 USD [2]. Dorman Products is a supplier of replacement and upgrade parts in the motor vehicle aftermarket industry, serving passenger cars, light, medium, and heavy-duty trucks, as well as specialty vehicles. The company's product classes include powertrain, chassis, motor vehicle body, and hardware. Its products are sold primarily through aftermarket retailers, dealers, distributors, and specialty markets.

QXO
Benchmark has initiated coverage on QXO with a "Buy" rating and a price target of $50.00 USD [3]. QXO operates in the semiconductor industry, providing advanced semiconductor solutions for various applications. The company's products are used in a wide range of industries, including automotive, consumer electronics, and industrial automation.

Immunome
Evercore ISI Group has initiated coverage on Immunome with an "Outperform" rating and a price target of $18.00 USD [4]. Immunome is a biotechnology company focused on developing and commercializing innovative immunotherapies. The company's pipeline includes several promising therapeutic candidates targeting various cancers and other diseases.

Conclusion
These analyst ratings and price targets provide valuable insights for investors looking to make informed decisions. The "Buy" and "Overweight" ratings suggest bullish sentiment, while the "Outperform" rating indicates strong confidence in Immunome's growth prospects. Investors should consider these new ratings as part of their investment strategy, taking into account the specific growth opportunities and risks associated with each company.

References:
[1] https://www.ainvest.com/news/stifel-initiates-coverage-netgear-ntgr-buy-rating-35-price-target-2508/
[2] https://www.marketscreener.com/news/wells-fargo-initiates-dorman-products-at-overweight-with-175-price-target-ce7c50dade88fe21
[3] https://www.gurufocus.com/news/3075309/stifel-initiates-coverage-on-netgear-ntgr-with-a-buy-rating-ntgr-stock-news
[4] https://uk.finance.yahoo.com/news/netgear-turnaround-under-ceo-could-160806627.html